About 30% to 40% of people with DLBCL experience relapse
following their first treatment.
Refractory
DLBCL occurs in about 10% of people treated for this cancer.
It’s important to remember that, even if you experience relapsed or refractory DLBCL, there’s still hope. Your healthcare team will work with you to help you understand your next steps forward.
Learn more about relapsed and refractory DLBCL >